May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Complement Factor H (CFH) and Apolipoprotein E (APOE) Gene Polymorphisms Are Risk Factors for Exsudative AMD
Author Affiliations & Notes
  • N. Leveziel
    Molecular Biology, INSERM U538, Paris, France
    Ophthalmology, Hopital Intercommunal de Créteil, Créteil, France
  • V. Frémeaux–Bacchi
    Immunology, INSERM U255, Paris, France
  • V. Barbu
    Inserm u680, Pierre et Marie Curie University, Paris, France
  • F. Richard
    Statistics and Epidemiology, INSERM U508, Lille, France
  • M. Dragon–Durey
    Immunology, INSERM U255, Paris, France
  • I. Gaudino
    Molecular Biology, INSERM U538, Paris, France
  • G. Coscas
    Ophthalmology, Hopital Intercommunal de Créteil, Créteil, France
  • G. Soubrane
    Ophthalmology, Hopital Intercommunal de Créteil, Créteil, France
  • P. Benlian
    Molecular Biology, INSERM U538, Paris, France
  • E.H. Souied
    Ophthalmology, Hopital Intercommunal de Créteil, Paris, France
  • Footnotes
    Commercial Relationships  N. Leveziel, None; V. Frémeaux–Bacchi, None; V. Barbu, None; F. Richard, None; M. Dragon–Durey, None; I. Gaudino, None; G. Coscas, None; G. Soubrane, None; P. Benlian, None; E.H. Souied, None.
  • Footnotes
    Support  Fondation Paulette Darty, INSERM
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4337. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Leveziel, V. Frémeaux–Bacchi, V. Barbu, F. Richard, M. Dragon–Durey, I. Gaudino, G. Coscas, G. Soubrane, P. Benlian, E.H. Souied; Complement Factor H (CFH) and Apolipoprotein E (APOE) Gene Polymorphisms Are Risk Factors for Exsudative AMD . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4337.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Age related macular degeneration (AMD) is a leading cause of visual impairment in industrialized countries. In a case control study, we screened polymorphisms of the Apo E gene, and of the recently identified complement factor H (CFH) susceptibility gene. Polymorphisms at these gene loci have been described as major genetic risk factors for AMD in different human populations. The aim of this study was to assess these gene polymorphisms in a French population specifically affected with exsudative AMD.

Methods: : A complete ophthalmological examination including best corrected visual acuity measurement, fundus examination and fluorescein angiography (FA) was performed 141 patients with exsudative AMD. AMD patients were classified in two subgroups: 1/ sporadic cases (n=60, mean age 74.9±5.7), 2/ familial cases (n=81, mean age 74.0±9.4). Genotypes in AMD patients were compared with healthy age and sex matched controls (n= 91, mean age 74.6±6.3). For CFH Y402H polymorphism, genotyping was performed by sequencing of PCR products including the polymorphism. For Apo E genotyping, allele discrimination was performed on genomic DNA extracted from blood leucocytes, by real–time PCR (ABI® assay on demand) on a mx3000 Stratagene® apparatus.

Results: : Genotypic distribution of the Y402H polymorphism were significantly different between sporadic cases versus controls (Chi² = 14.48 [2 df], p<0.0007) and between familial cases versus controls (Chi² = 23.78 [2 df], p<0.0001). In familial cases, the OR for AMD risk were 3.6 CI 95% [1.7–7.6] for CT heterozygotes and OR= 8.0 CI 95% [3.2–19.8] for CC homozygotes. Genotypic distribution for Apo E polymorphisms were also significantly different between cases and control cases (Chi² = 4.7 [1 df], p<0.05). The OR for AMD risk were 1.74 CI 95% [0.68–4.44] for the Apo E2 carriers, and 0.48 CI 95% [0.22–1.3] for the Apo E4 carriers.

Conclusions: : Here we confirm the involvement of the CFH Y402H polymorphism, and of the Apo E polymorphisms as risk factors for exsudative AMD in a French population. Screening for candidate genes appears of importance to understand biological processes underlying AMD and to predict individual risk of AMD.

Keywords: genetics • age-related macular degeneration • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×